Picture of Cidara Therapeutics logo

CDTX — Cidara Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapNeutral

Deals of the day-Mergers and acquisitions

Nov 14 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1030 GMT on Friday:

** Pan-European stock exchange operator Euronext ENX.PA said its tender offer for 100% of Hellenic Exchanges EXCr.AT — the operator of the Athens bourse — had become unconditional, following an approval from the Greek market regulator. nL1N3WQ09G

** Merck MRK.N is closing in on a deal to buy Cidara Therapeutics CDTX.O in a deal valuing the biotechnology company at a premium to its $3.3 billion market capitalization, the Financial Times reported on Thursday. nL4N3WP1VC

 (Compiled by Rajarshi Roy and Anhata Rooprai in Bengaluru)

 ((Anhata.Rooprai@thomsonreuters.com))

Recent news on Cidara Therapeutics

See all news